PIPE-791
Asset
Small molecule inhibitor of lysophosphatidic acid receptor 1 (LPA1) to reduce fibrosis.
- Stage
- Phase 2
- Modality
- Small molecule
- Target
- Inflammation
- 1
- Indication
- 1
- Trial
- 1
- Developer
Indications
1Idiopathic pulmonary fibrosis
Phase 2, Recruiting, NCT07284459, clinicaltrials.gov, 7 Oct 2026
In the full profile
- Targets and what it contains2
- Owner and partners1
- Trials1
- Evidence for its targets2
- Competitors12
- Signals1
Every asset’s record: target, stage, trials and the evidence behind it.